Skip to main content
Drug bottle and Pill

Compare Vemlidy vs. Videx

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tenofovir alafenamide (Vemlidy) and didanosine (Videx) are both antiretroviral (ARV) medications that belong to the nucleoside reverse transcriptase inhibitor (NRTI) class. They are used to treat viral infections, but they target different viruses. Tenofovir alafenamide is FDA-approved for treating hepatitis B virus (HBV) in people ages 6 and older, while didanosine was used for treating human immunodeficiency virus (HIV) before it was discontinued. Vemlidy is taken once daily with food, whereas Videx was also taken orally but is no longer available in the U.S. Vemlidy is only available as a brand-name medication, while Videx had no generic versions before being discontinued. Common side effects of Vemlidy include headache, stomach pain, and cough, while Videx had serious side effects that limited its use. Vemlidy can interact with certain medications like NSAIDs, which can increase the risk of kidney damage, whereas Videx had interactions with other HIV ARVs.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.